“Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis” (2015) Archivio Italiano di Urologia e Andrologia, 87(2), pp. 121–129. doi:10.4081/aiua.2015.2.121.